ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$1.59
+0.00 (+0.00%)
Open$1.61
Previous Close$1.59
Day High$1.67
Day Low$1.53
52W High$1.72
52W Low$0.74
Volume—
Avg Volume206.4K
Market Cap40.87M
P/E Ratio3.61
EPS$0.36
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,171.1% upside
Current
$1.59
$1.59
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 82.9K | 186.8K | 4.99M |
| Net Income | -31,049,844 | -62,981,427 | -1,193,914 |
| Profit Margin | -37,652.2% | -35,769.6% | -23.9% |
| EBITDA | -33,053,521 | -70,770,441 | -1,575,968 |
| Free Cash Flow | — | — | -691,464 |
| Rev Growth | -55.6% | -55.6% | +20.9% |
| Debt/Equity | 0.00 | 0.00 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |